As of 2026-03-23, the Relative Valuation of Arcturus Therapeutics Holdings Inc (ARCT) is (50.07) USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.63 USD, the upside of Arcturus Therapeutics Holdings Inc based on Relative Valuation is -855.2%.
The range of the Relative Valuation is (45.01) - (53.44) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.4x - 25.3x | 22.2x |
| Forward P/E multiples | 19.4x - 23.1x | 21.1x |
| Fair Price | (45.01) - (53.44) | (50.07) |
| Upside | -778.9% - -906.1% | -855.2% |
| Date | P/E |
| 2026-03-20 | -2.86 |
| 2026-03-19 | -2.90 |
| 2026-03-18 | -2.83 |
| 2026-03-17 | -2.76 |
| 2026-03-16 | -2.86 |
| 2026-03-13 | -2.88 |
| 2026-03-12 | -3.02 |
| 2026-03-11 | -3.22 |
| 2026-03-10 | -3.29 |
| 2026-03-09 | -3.18 |
| 2026-03-06 | -3.07 |
| 2026-03-05 | -3.13 |
| 2026-03-04 | -3.27 |
| 2026-03-03 | -3.42 |
| 2026-03-02 | -3.61 |
| 2026-02-27 | -3.55 |
| 2026-02-26 | -3.59 |
| 2026-02-25 | -3.58 |
| 2026-02-24 | -3.53 |
| 2026-02-23 | -3.31 |
| 2026-02-20 | -3.31 |
| 2026-02-19 | -3.44 |
| 2026-02-18 | -3.24 |
| 2026-02-17 | -3.20 |
| 2026-02-13 | -3.11 |
| 2026-02-12 | -3.10 |
| 2026-02-11 | -3.20 |
| 2026-02-10 | -3.27 |
| 2026-02-09 | -3.25 |
| 2026-02-06 | -3.27 |
| 2026-02-05 | -3.03 |
| 2026-02-04 | -3.17 |
| 2026-02-03 | -3.16 |
| 2026-02-02 | -3.18 |
| 2026-01-30 | -3.23 |
| 2026-01-29 | -3.27 |
| 2026-01-28 | -3.18 |
| 2026-01-27 | -3.22 |
| 2026-01-26 | -3.18 |
| 2026-01-23 | -3.25 |
| 2026-01-22 | -3.28 |
| 2026-01-21 | -3.14 |
| 2026-01-20 | -3.07 |
| 2026-01-16 | -3.15 |
| 2026-01-15 | -3.29 |
| 2026-01-14 | -3.34 |
| 2026-01-13 | -3.27 |
| 2026-01-12 | -3.25 |
| 2026-01-09 | -2.93 |
| 2026-01-08 | -2.92 |